Metabolomics Workbench : NIH Data Repository

Reversed phase NEGATIVE ION MODE (Analysis AN005134)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9
2-(5-Oxovaleryl)phosphatidylcholine	ME819127	0.66	1.25	1.20	1.44	0.72	0.83	1.14	1.79	0.88
2,2^-Methylenebis(ethyl-6-tert-butylphenol)	ME819126	1.21	0.72	0.95	0.98	1.04	1.06	1.48	1.42	0.62
3.alpha.-Mannobiose_3	ME819131	1.08	1.00	0.96	0.95	0.81	0.81	1.06	0.93	1.10
1,2-Distearoyl-sn-glycero-3-phospho-(1^-rac-glycerol)	ME819123	1.24	1.06	0.93	0.88	1.31	0.97	1.45	0.72	0.62
3.alpha.-Mannobiose_2	ME819130	1.14	1.23	1.07	0.91	1.18	1.30	1.18	0.95	0.76
4-O-.beta.-Galactopyranosyl-D-mannopyranose_2	ME819133	1.02	1.01	1.00	0.97	1.03	1.01	1.03	0.98	0.97
14-HDoHE	ME819117	0.73	0.73	1.00	0.72	1.76	2.76	1.42	1.16	0.39
6.alpha.-Mannobiose	ME819134	1.06	0.95	0.96	0.94	0.86	1.03	1.18	0.96	0.95
12-HETE	ME819116	0.76	1.04	1.23	1.01	1.02	2.63	1.25	1.30	0.46
13(S)-HODE	ME819124	1.17	1.36	0.81	1.02	1.38	1.87	1.45	0.67	0.42
4-O-.beta.-Galactopyranosyl-D-mannopyranose	ME819132	1.01	0.99	1.16	0.99	1.21	NA	1.22	0.77	0.85
[2-hydroxy-3-[hydroxy-[2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] octadecanoate	ME819136	0.90	1.12	1.06	1.12	1.06	1.45	1.08	1.11	0.83
16:0-succinoyl PC	ME819125	0.77	1.74	1.39	1.30	0.76	0.89	1.04	1.19	0.81
2-(5-Oxovaleryl)phosphatidylcholine_2	ME819128	0.75	1.20	1.26	1.43	0.76	0.90	1.08	1.27	0.82
3.alpha.-Mannobiose	ME819129	1.01	1.14	0.96	1.21	0.98	NA	1.09	1.08	0.97

F1	Sample source:MBlood \| exposure:ctl \| timepoint:12
F2	Sample source:MBlood \| exposure:ctl \| timepoint:2
F3	Sample source:MBlood \| exposure:ctl \| timepoint:24
F4	Sample source:MBlood \| exposure:ctl \| timepoint:5
F5	Sample source:MBlood \| exposure:lps \| timepoint:12
F6	Sample source:MBlood \| exposure:lps \| timepoint:2
F7	Sample source:MBlood \| exposure:lps \| timepoint:24
F8	Sample source:MBlood \| exposure:lps \| timepoint:5
F9	Sample source:MBlood \| exposure:- \| timepoint:-

Data matrix